A2843G promoter polymorphism of the ANP gene was reported to be associated with left ventricular hypertrophy in patients with hypertension [12] while The ScaI polymorphism of the ANP gene was reported to be an important additive genetic factor influencing neurohormonal activation and disease progression in severe heart failure (HF). Here, NPPA is linked to hypertensive disorder.